BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9539788)

  • 21. Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1.
    Leenders W; Lubsen N; van Altena M; Clauss M; Deckers M; Löwik C; Breier G; Ruiter D; de Waal R
    Lab Invest; 2002 Apr; 82(4):473-81. PubMed ID: 11950904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
    Piossek C; Schneider-Mergener J; Schirner M; Vakalopoulou E; Germeroth L; Thierauch KH
    J Biol Chem; 1999 Feb; 274(9):5612-9. PubMed ID: 10026178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells.
    Thieme H; Aiello LP; Takagi H; Ferrara N; King GL
    Diabetes; 1995 Jan; 44(1):98-103. PubMed ID: 7529203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
    Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
    J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
    Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
    Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
    Mechtcheriakova D; Schabbauer G; Lucerna M; Clauss M; De Martin R ; Binder BR; Hofer E
    FASEB J; 2001 Jan; 15(1):230-242. PubMed ID: 11149911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
    Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
    J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF(165) and VEGF(165).KDR Complexes.
    Hamma-Kourbali Y; Vassy R; Starzec A; Le Meuth-Metzinger V; Oudar O; Bagheri-Yarmand R; Perret G; Crépin M
    J Biol Chem; 2001 Oct; 276(43):39748-54. PubMed ID: 11514538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
    Muller YA; Christinger HW; Keyt BA; de Vos AM
    Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
    Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells.
    D'Angelo G; Martini JF; Iiri T; Fantl WJ; Martial J; Weiner RI
    Mol Endocrinol; 1999 May; 13(5):692-704. PubMed ID: 10319320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells.
    Murata M; Kador PF; Sato S
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 and p100 in endothelial cells.
    Wong EY; Morgan L; Smales C; Lang P; Gubby SE; Staddon JM
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):209-16. PubMed ID: 10657259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro.
    Bell C; Lynam E; Landfair DJ; Janjic N; Wiles ME
    In Vitro Cell Dev Biol Anim; 1999 Oct; 35(9):533-42. PubMed ID: 10548435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.